Smoking and p53 Overexpression in Colorectal Cancer
Author Information
Author(s): AN Freedman, AM Michalek, JR Marshall, CJ Mettlin, NJ Petrelli, Z-F Zhang, JD Black, S Satchidanand, JE Asirwatham
Primary Institution: Roswell Park Cancer Institute
Hypothesis
Is p53 protein overexpression in colorectal cancer associated with cigarette smoking exposure?
Conclusion
p53 overexpression appears to be associated with smoking exposure in colorectal cancer.
Supporting Evidence
- Ex-smokers had an odds ratio of 1.34 for colorectal cancer compared to non-smokers.
- Current smokers had an odds ratio of 1.13 for colorectal cancer compared to non-smokers.
- A significant trend of increasing risk was observed for total pack-years of smoking (p=0.03).
- 44.8% of colorectal tumors showed p53 overexpression.
- Patients with a positive family history of colorectal cancer were more likely to have p53-negative tumors.
Takeaway
This study found that smoking may increase the risk of certain types of colorectal cancer, especially those without p53 overexpression.
Methodology
The study analyzed 163 colorectal cancer cases and 326 healthy controls using questionnaires and immunohistochemical analysis for p53 overexpression.
Potential Biases
Potential bias from using hospital/screening clinic controls.
Limitations
The use of hospital controls may introduce bias as they may represent healthier lifestyles.
Participant Demographics
56% male, 96% white, ages ranged from under 55 to over 75.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI 0.85-2.12
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website